tiprankstipranks
Advertisement
Advertisement

Polymarket Earnings: Will CVX, XOM, MRNA Beat Earnings Tomorrow?

Story Highlights
  • Chevron, Exxon Mobil, and Moderna will report their earnings tomorrow.
  • Chevron has the highest odds of beating earnings, while Moderna has the lowest, according to Polymarket.
Polymarket Earnings: Will CVX, XOM, MRNA Beat Earnings Tomorrow?

On Friday, May 1, Chevron (CVX), Exxon Mobil (XOM), and Moderna (MRNA) will report their earnings. All three companies will report before the market open. Traders are already weighing in with their expectations on Polymarket.

Claim 55% Off TipRanks

Wall Street’s Earnings Estimates

  • Chevron is expected to report an adjusted EPS of $1.00.
  • Exxon Mobil is expected to report an adjusted EPS of $1.00.
  • Moderna is expected to report a GAAP EPS loss of $2.67.

What is Polymarket?

Polymarket is a prediction platform where traders bet on the outcomes of real-world events, including earnings reports, elections, and economic indicators. Polymarket odds reflect expectations and can provide insight into investor sentiment.

Will Chevron Beat Earnings?

Chevron has beaten or met earnings estimates during 12 of the past 18 quarters for a success rate of 66.67%. Polymarket gives the multinational energy company an 81% chance of beating its estimated adjusted EPS of $1.00.

Will Exxon Mobil Beat Earnings?

Exxon Mobil has beaten or met earnings estimates during 14 of the past 18 quarters for a success rate of 77.78%. Polymarket gives the oil and gas giant a 73% chance of beating its estimated adjusted EPS of $1.00.

Will Moderna Beat Earnings?

Moderna has beaten or met earnings estimates during 13 of the past 18 quarters for a success rate of 72.22%. Polymarket traders give the biotechnology company a 93% chance of surpassing its estimated GAAP EPS loss of $2.67.

Disclosure: Polymarket odds reflect expectations, not guaranteed outcomes. The odds represent the views and expectations of traders, but actual earnings results can differ significantly from these predictions. Investors should treat Polymarket data as just one tool when evaluating their investment decisions.

Disclaimer & DisclosureReport an Issue

1